2019 annual financial data
Senti Biosciences Holdings 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -21,621.18%.
Operating income was -21,782,000 USD and net income was -21,157,000 USD.
Operating cash flow was -18,378,000 USD.
Get free Senti Biosciences Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 85,000 USD
- Operating income
- -21,782,000 USD
- Net income
- -21,157,000 USD
- Operating cash flow
- -18,378,000 USD